The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and low Karnofsky performance status: Results from the CheckMate 920 trial.
 
Thomas E. Hutson
Employment - Texas Oncology
Honoraria - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Pfizer (Inst)
 
Bradley Curtis Carthon
Consulting or Advisory Role - Eisai
Research Funding - Alkermes (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jeffrey Yorio
Consulting or Advisory Role - Bristol-Myers Squibb
 
Sunil Babu
Employment - Fort Wayne Medical Oncology & Hematology
Stock and Other Ownership Interests - Fort Wayne Medical Oncology & Hematology; Lutheran hospital (I)
Honoraria - Alexion Pharmaceuticals; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly
Consulting or Advisory Role - Alexion Pharmaceuticals; argenx; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb
Speakers' Bureau - Alexion Pharmaceuticals
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); argenx (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Novartis (Inst); Sanofi (Inst); Syndax (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Lilly
 
Heidi Ann McKean
No Relationships to Disclose
 
Ivor John Percent
No Relationships to Disclose
 
Scott S. Tykodi
Consulting or Advisory Role - Bristol-Myers Squibb; Intellisphere, LLC; Merck; Natera
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Clinigen Group (Inst); Exelixis (Inst); Genentech (Inst); Jounce Therapeutics (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending (Inst)
 
Michael Roger Harrison
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Fujifilm; Genentech; Janssen Oncology; Pfizer
Speakers' Bureau - Exelixis; Genentech
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Joshua Zhang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jesus Zoco
Employment - Syneos Health
Consulting or Advisory Role - Syneos Health
 
Jennifer L. Johansen
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Daniel J. George
Leadership - Capio BioSciences
Honoraria - Acceleron Pharma; American Association for Cancer Research; Axess Oncology; Bayer; EMD Serono; Exelixis; Janssen Oncology; Millennium Medical Publishing; OncLive; Pfizer; Sanofi; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Pfizer; Sanofi; Vizuri
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi; UroToday